IMI2- Call 17 published
The Innovative Medicines Initiative 2 (IMI2) hast published the 17th call. It addresses the following topics:
- Topic 1: Optimising future obesity treatment
- Topic 2: Open access chemogenomics library and chemical probes for the druggable genome
- Topic 3: Intelligent prediction and identification of environmental risks posed by human medicinal products
The budget is 84 mio € whereby the applicants are supported with 41 mio €.
The first stage proposal deadline is April 25, 2019.
Details to the call are found here:
ConsulTech supports applicants with its long-lasting experience in elaborating competetive proposals. We are the project management partner in the IMI2 consortium "IMI-PAINCARE".